Steve Valiquette

Stock Analyst at Barclays

(1.42)
# 3,597
Out of 5,115 analysts
152
Total ratings
45.1%
Success rate
-4.29%
Average return

Stocks Rated by Steve Valiquette

Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8$9.5
Current: $15.00
Upside: -36.67%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10$12
Current: $5.45
Upside: +120.18%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596$616
Current: $831.21
Upside: -25.89%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8$9
Current: $2.27
Upside: +296.48%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12$10
Current: $5.02
Upside: +99.20%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25$24
Current: $16.79
Upside: +42.94%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89$86
Current: $74.52
Upside: +15.41%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86$85
Current: $43.32
Upside: +96.21%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275$300
Current: $488.27
Upside: -38.56%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35$34
Current: $36.47
Upside: -6.77%
Maintains: Overweight
Price Target: $70$105
Current: $189.28
Upside: -44.53%
Maintains: Overweight
Price Target: $57$55
Current: $77.67
Upside: -29.19%
Maintains: Equal-Weight
Price Target: $15$13
Current: $18.73
Upside: -30.59%
Upgrades: Equal-Weight
Price Target: $132$142
Current: $201.26
Upside: -29.44%
Maintains: Underweight
Price Target: $13$5
Current: $31.85
Upside: -84.30%
Initiates: Equal-Weight
Price Target: $57
Current: $94.53
Upside: -39.70%
Maintains: Overweight
Price Target: $78$82
Current: $188.36
Upside: -56.47%
Maintains: Overweight
Price Target: $20$18
Current: $17.24
Upside: +4.41%
Maintains: Equal-Weight
Price Target: $33$31
Current: $43.88
Upside: -29.35%
Maintains: Overweight
Price Target: $400$375
Current: $179.59
Upside: +108.81%
Maintains: Equal-Weight
Price Target: $20$19
Current: $37.34
Upside: -49.12%
Maintains: Overweight
Price Target: $500$570
Current: $195.20
Upside: +192.01%
Downgrades: Equal-Weight
Price Target: $70$64
Current: $214.88
Upside: -70.22%
Maintains: Overweight
Price Target: $275$310
Current: $274.11
Upside: +13.09%
Maintains: Overweight
Price Target: $495$565
Current: $286.93
Upside: +96.91%
Downgrades: Equal-Weight
Price Target: $150$75
Current: $2.16
Upside: +3,372.22%
Upgrades: Overweight
Price Target: $26$19
Current: $5.55
Upside: +242.34%
Maintains: Underweight
Price Target: $6$10
Current: $3.21
Upside: +211.53%
Initiates: Overweight
Price Target: $20
Current: $8.40
Upside: +138.10%
Reinstates: Overweight
Price Target: $260
Current: $88.42
Upside: +194.05%